Efficacy and safety of Rivaroxaban compared with Warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban once daily, oral, direct factor Xa inhibition compared with Vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation (ROCKET AF)

HALPERIN J. L.;HANKEY G. J.;WOJDYLA D. M.;PICCINI J. P.;LOKHNYGINA Y.;PATEL M. R.;BREITHARDT G.;SINGER D. E.;BECKER R. C.;HACKE W.;PAOLINI J. F.;NESSEL C. C.;MAHAFFEY K. W.;CALIFF R. M.;FOX K. A. A. on behalf of the ROCKET AF;CAROLEI, ANTONIO;as member of Steering Committee;Investigators

2014-01-01